Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases
Authors
Keywords
Rituximab, Late onset neutropenia, Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies, Neuromyelitis optica spectrum disorders (NMOSD), Multiple sclerosis
Journal
Multiple Sclerosis and Related Disorders
Volume 41, Issue -, Pages 102019
Publisher
Elsevier BV
Online
2020-02-23
DOI
10.1016/j.msard.2020.102019

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.